Fermenta Biotech Limited — Important, 04-09-2026: Updates
04-09-2026 | 04:33 pm
04-09-2026 | 04:33 pm
Fermenta Biotech has announced a board meeting on August 11, 2026, which approved the financial results for the quarter ended June 30, 2026. Standalone revenue was ₹111.84 Cr, profit ₹14.99 Cr. Consolidated revenue reached ₹121.82 Cr, profit ₹9.53 Cr. The company also reversed a ₹2.05 Cr inventory provision and granted 3,95,400 ESOPs.
No comments yet. Be the first to comment!
